Terms: = Germ cell tumor AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Treatment
182 results:
1. Association of Schimmelpenning Syndrome with Astrocytoma (WHO Grade 3): Case Report.
Tumova A; Auslands K; Millers A; Priede Z; Buks M; Ozola A; Ozoliņa E; Bicāns K; Ulmanis R
Medicina (Kaunas); 2024 Oct; 60(10):. PubMed ID: 39459475
[TBL] [Abstract] [Full Text] [Related]
2. Survival outcomes and molecular drivers of testicular cancer in hispanic men.
Rezaee ME; Elias R; Li HL; Agrawal P; Pallauf M; Enikeev D; Ged Y; Eggener S; Singla N
Urol Oncol; 2024 Sep; 42(9):293.e1-293.e7. PubMed ID: 38821727
[TBL] [Abstract] [Full Text] [Related]
3. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
[TBL] [Abstract] [Full Text] [Related]
4. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
[No Abstract] [Full Text] [Related]
5. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in
Zhang H; Read A; Cataisson C; Yang HH; Lee WC; Turk BE; Yuspa SH; Luo J
Sci Signal; 2024 May; 17(836):eadd5073. PubMed ID: 38743809
[TBL] [Abstract] [Full Text] [Related]
6. Genomic and Transcriptomic Landscape of RET Wild-Type Medullary Thyroid Cancer and Potential Use of Mitogen-Activated Protein Kinase-Targeted Therapy.
Darabi S; Adeyelu T; Elliott A; Sukari A; Hodges K; Abdulla F; Zuazo CE; Wise-Draper T; Wang T; Demeure MJ
J Am Coll Surg; 2024 Jul; 239(1):50-60. PubMed ID: 38651727
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing kras stability.
Zhao F; Yao Z; Li Y; Zhao W; Sun Y; Yang X; Zhao Z; Huang B; Wang J; Li X; Chen A
Cancer Lett; 2024 May; 590():216844. PubMed ID: 38582394
[TBL] [Abstract] [Full Text] [Related]
8. Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities.
Li B; Zhao S; Li S; Li C; Liu W; Li L; Cui B; Liu X; Chen H; Zhang J; Ren Y; Liu F; Yang M; Jiang T; Liu Y; Qiu X
Neuro Oncol; 2024 Jul; 26(7):1335-1351. PubMed ID: 38430549
[TBL] [Abstract] [Full Text] [Related]
9. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
10. kras is a molecular determinant of platinum responsiveness in glioblastoma.
Zuchegna C; Leone S; Romano A; Porcellini A; Messina S
BMC Cancer; 2024 Jan; 24(1):77. PubMed ID: 38225605
[TBL] [Abstract] [Full Text] [Related]
11. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.
Iorgulescu JB; Ruthen N; Ahn R; Panagioti E; Gokhale PC; Neagu M; Speranza MC; Eschle BK; Soroko KM; Piranlioglu R; Datta M; Krishnan S; Yates KB; Baker GJ; Jain RK; Suvà ML; Neuberg D; White FM; Chiocca EA; Freeman GJ; Sharpe AH; Wu CJ; Reardon DA
Front Immunol; 2023; 14():1297932. PubMed ID: 38213329
[TBL] [Abstract] [Full Text] [Related]
12. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract] [Full Text] [Related]
13. The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis.
de Sauvage MA; Torrini C; Nieblas-Bedolla E; Summers EJ; Sullivan E; Zhang BS; Batchelor E; Marion B; Yamazawa E; Markson SC; Wakimoto H; Nayyar N; Brastianos PK
Neuro Oncol; 2024 May; 26(5):889-901. PubMed ID: 38134951
[TBL] [Abstract] [Full Text] [Related]
14. First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations.
Janku F; Kim TM; Iyer G; Spreafico A; Elez E; de Jonge M; Yamamoto N; van der Wekken AJ; Ascierto PA; Maur M; Marmé F; Kiladjian JJ; Basu S; Baffert F; Buigues A; Chen C; Cooke V; Giorgetti E; Kim J; McCarthy F; Moschetta M; Dummer R
Eur J Cancer; 2024 Jan; 196():113458. PubMed ID: 38039779
[TBL] [Abstract] [Full Text] [Related]
15. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
16. The Unmet Diagnostic and treatment Needs in Large cell Neuroendocrine Carcinoma of the Lung.
Buium C; Negru S; Ionescu DN; Dediu M
Curr Oncol; 2023 Jul; 30(8):7218-7228. PubMed ID: 37623004
[TBL] [Abstract] [Full Text] [Related]
17. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis.
Zheng K; Hao F; Medrano-Garcia S; Chen C; Guo F; Morán-Blanco L; Rodríguez-Perales S; Torres-Ruiz R; Peligros MI; Vaquero J; Bañares R; Gómez Del Moral M; Regueiro JR; Martínez-Naves E; Mohamed MR; Gallego-Durán R; Maya D; Ampuero J; Romero-Gómez M; Gilbert-Ramos A; Guixé-Muntet S; Fernández-Iglesias A; Gracia-Sancho J; Coll M; Graupera I; Ginès P; Ciudin A; Rivera-Esteban J; Pericàs JM; Frutos MD; Ramos Molina B; Herranz JM; Ávila MA; Nevzorova YA; Fernández-Malavé E; Cubero FJ
Cell Death Dis; 2023 Aug; 14(8):514. PubMed ID: 37563155
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic biomarkers for survival in mucosal melanoma.
Thierauf JC; Kaluziak ST; Codd E; Dybel SN; Jobbagy S; Purohit R; Farahani AA; Dedeilia A; Naranbhai V; Hoang MP; Fisch AS; Ritterhouse L; Boland GM; Lennerz JK; Iafrate AJ
Pigment Cell Melanoma Res; 2023 Sep; 36(5):378-387. PubMed ID: 37390098
[TBL] [Abstract] [Full Text] [Related]
19. Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.
Scherzad A; Stöth M; Meyer TJ; Haug L; Gehrke T; Schilling B; Meierjohann S; Scheich M; Hagen R; Gesierich A; Hackenberg S
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4215-4223. PubMed ID: 37272953
[TBL] [Abstract] [Full Text] [Related]
20. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
[Next]